USPTO serial 79232309
ASCELIA
Reviewed by CopyMark Law Group
Reg. 5706074Status 709
- Filing date
- Status date
- Registration date
- Mar 26, 2019
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ASCELIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1100 New York Avenue, N.W.Washington, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemical products for scientific purposes; biochemicals for in vitro and in vivo scientific use; chemicals for use in vitro scientific use | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals, medical and veterinary preparations namely, diagnostic agents, diagnostic reagents, contrast media, and contrast agents for use in medical diagnostic imaging in the nature of magnetic resonance imaging; contrast media and contrast agents for use in-vivo imaging; contrast media and contrast agents for use in vitro imaging | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and design in the field of pharmaceuticals, medical imaging; industrial analysis and research services in the field of pharmaceuticals, medical imaging; bacteriological and biological research; conducting clinical trials for others; research and development of new products for others; scientific laboratory services | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; advisory and consulting services relating to the use of medical and diagnostic products in medical and medical diagnostic examination; advisory and consulting services relating to use of contrast media and contrast agents in medical and medical diagnostic examinations; advisory and consulting services relating to the use of medical and medical diagnostic imaging technologies; medical and medical diagnostic consulting services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ascelia Pharma AB
- Other trademarks owned by Ascelia Pharma AB
- Other trademarks owned by Ascelia Pharma AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ASCELIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 10, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 10, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 6, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 16, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 16, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 30, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 30, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 26, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 26, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 21, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 20, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 20, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 20, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 20, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 19, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 13, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 30, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 6, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 27, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 26, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 18, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 17, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |